EAGLE PHARMACEUTICALS, INC. Annual Return On Equity in % from 2015 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Eagle Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2015 to 2022.
  • Eagle Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2023 was 4.98 %, a 55.5% decline year-over-year.
  • Eagle Pharmaceuticals, Inc. annual Return On Equity for 2022 was 15.5 %.
  • Eagle Pharmaceuticals, Inc. annual Return On Equity for 2021 was -4.62 %, a 170% decline from 2020.
  • Eagle Pharmaceuticals, Inc. annual Return On Equity for 2020 was 6.62 %, a 18.8% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 15.5 +20.1 Jan 1, 2022 Dec 31, 2022
2021 -4.62 -11.2 -170% Jan 1, 2021 Dec 31, 2021
2020 6.62 -1.53 -18.8% Jan 1, 2020 Dec 31, 2020
2019 8.15 -9.61 -54.1% Jan 1, 2019 Dec 31, 2019
2018 17.8 -12.7 -41.7% Jan 1, 2018 Dec 31, 2018
2017 30.5 -40.9 -57.3% Jan 1, 2017 Dec 31, 2017
2016 71.3 +68.6 +2516% Jan 1, 2016 Dec 31, 2016
2015 2.73 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.